|
Santos Mateo JJ, Sabater Molina M, Gimeno Blanes JR. Hypertrophic cardiomyopathy. Med Clin (Barc). 2018 Jun 8;150(11):434-442. doi: 10.1016/j.medcli.2017.09.013. Epub 2017 Nov 14. Review. English, Spanish. PubMed PMID: 29150126.
AÑO: 2018; IF: 1.277
|
29150126
|
Serratosa-Fernández L, Pascual-Figal D, Masiá-Mondéjar MD, Sanz-de la Garza M, Madaria-Marijuan Z, Gimeno-Blanes JR, Adamuz C; Grupo de Cardiología del Deporte de la Sociedad Española de Cardiología. Comments on the New International Criteria for Electrocardiographic Interpretation in Athletes. Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):983-990. doi: 10.1016/j.rec.2017.08.015. Epub 2017 Sep 18. English, Spanish. PubMed PMID: 28928069.
AÑO: 2017; IF: 5.166
|
|
Dominguez F, Climent V, Zorio E, Ripoll-Vera T, Salazar-Mendiguchía J, García-Pinilla JM, Urbano-Moral JA, Fernández-Fernández X, Lopez-Cuenca D, Ajo-Ferrer R, Sanz-Sanchez J, Gomez-Perez Y, López-Garrido MA, Barriales-Villa R, Gimeno JR, Garcia-Pavia P. Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation. Int J Cardiol. 2017 Dec 1;248:232-238. doi: 10.1016/j.ijcard.2017.08.010. Epub 2017 Aug 7. PubMed PMID: 28811092.
AÑO: 2017; IF: 4.034
|
|
Perez-Sanchez I, Sabater-Molina M, Rocamora MEN, Glover G, Escudero F, de Mingo Casado P, Gimeno-Blanes JR. Phenotypic Characterization of a Family With An In-frame Deletion in the DMD Gene and Variable Penetrance. Curr Gene Ther. 2018;18(4):246-251. doi: 10.2174/1566523218666180709125346. PubMed PMID: 29984652.
AÑO: 2018; IF: 2.218
|
|
Pérez-Sánchez I, Sabater-Molina M, Muñoz-Esparza C, Gimeno-Blanes JR. Phenotype-modifying Factors in Hypertrophic Cardiomyopathy. Response. Rev Esp Cardiol (Engl Ed). 2018 Sep;71(9):770-771. doi: 10.1016/j.rec.2018.04.023. Epub 2018 Jun 25. English, Spanish. PubMed PMID: 29954718.
AÑO: 2018; IF: 5.126
|